SCHEMBL20128503

SCHEMBL20128503

CC(C)C(C)Cc1ccc(OC(F)F)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 2/20 0.50
ALOX15 P16050 8/20 0.44
ALOX12 P18054 5/20 0.44
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
LMNA P02545 5/20 0.43
ALDH1A1 P00352 4/20 0.43
HTT P42858 3/20 0.43
MAPT P10636 3/20 0.43
NR3C1 P04150 2/20 0.41
FOS P01100 1/20 0.41
TTR P02766 1/20 0.41
JUN P05412 1/20 0.41
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40
PNMT P11086 1/20 0.40
HPGD P15428 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18182095 0.87 CSNK2A1 (0.53) CSNK2A1ALOX12MEN1KMT2ALMNA
SCHEMBL18174199 0.81 MAPT (0.49) CSNK2A1ALOX12MEN1KMT2ALMNA
SCHEMBL10274466 0.80 CSNK2A1 (0.51) CSNK2A1ALOX12MEN1KMT2ALMNA
SCHEMBL20128505 0.80 ALOX15 (0.43) CSNK2A1ALOX15ALOX12NR3C1FOS
SCHEMBL900877 0.77 CSNK2A1 (0.47) CSNK2A1ALOX12MEN1KMT2ALMNA
SCHEMBL10980030 0.77 SMN1; SMN2 (0.48) CSNK2A1ALOX12MEN1KMT2ALMNA
SCHEMBL20128504 0.76 PNMT (0.66) ALOX15ALOX12MEN1KMT2ALMNA
SCHEMBL20061665 0.75 PNMT (0.46) ALOX15ALOX12MEN1KMT2ALMNA
SCHEMBL10983789 0.74 MEN1 (0.51) CSNK2A1ALOX12MEN1KMT2ALMNA
SCHEMBL12768177 0.73 CSNK2A1 (0.70) CSNK2A1MEN1KMT2ALMNAPNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180127402-A1 ISOXAZOLYL SUBSTITUTED BENZIMIDAZOLES CELLCENTRIC LTD (GB) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180127402-A1 ISOXAZOLYL SUBSTITUTED BENZIMIDAZOLES EP300, HDAC3, HDAC1 CSNK2A1 456/4885ALOX15 4701/4885ALOX12 4667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.